Genetic Control of Susceptibility to Testicular Cancer
Genetic Control of Susceptibility to Testicular Cancer
批准号:
7254184
负责人:
JOSEPH H. NADEAU
金额:
$45.34万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-06-01 至 2009-05-31
关键词:
AdenosineAffectBindingBiologyCell LineageCellular biologyChildChildhoodChildhood Testicular Germ Cell TumorComplementary DNAComplexCytidineCytidine DeaminaseDevelopmentEarly treatmentEnhancersEnvironmental Risk FactorEnzymesFamilyFetal DevelopmentFoundationsFrequenciesGene MutationGenesGeneticGenetic Complementation TestGenetic MarkersGenetic Predisposition to DiseaseGonadal DysgenesisGrantHumanInbred StrainInbred Strains MiceIncidenceIndividualInfertilityInheritedInosineKITLG geneLeadMalignant NeoplasmsMalignant neoplasm of testisMeasuresMedical SurveillanceMembraneMolecularMolecular AnalysisMusMutant Strains MiceMutationNatureNonsense MutationPluripotent Stem CellsPredispositionProcessRNARNA EditingRateRiskRisk FactorsRoleSequence AnalysisStem cellsStructure of primordial sex cellTP53 geneTesticular Germ Cell TumorTestingTransgenic MiceTumor Suppressor ProteinsUridineY Chromosomebasecongenicdevelopmental geneticsdsRNA adenosine deaminaseloss of functionmalemenmutantsextumortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Testicular germ cells tumors (TGCTs) are the most common cancer affecting young men and their incidence has been rising dramatically world-wide. Genetic markers for inherited risk are needed to identify susceptible individuals for regular surveillance and early treatment. Many TGCTs arise from primordial germ cells (PGCs) during fetal development. Little is known about the genetics or biology of this pluripotent stem cell lineage. The 129 family of inbred strains are the only strains in which spontaneous TGCTs occur at an appreciable frequency (5%). Several single gene mutations such as Ter, Ay and SI modulate susceptibility on the sensitized 129 genetic background. These strains and mutants are the foundation for genetic and developmental studies of PGC development and TGCT susceptibility. During the previous grant period, we showed that (a) Ter, the most potent TGCT modifier known, results from a mutation in the Deadend gene, (b) the TGCT suppressor at the Ay locus is Raly or Eif2b2 but not agouti, and also that the MGF enhancer is located in a 120 kb interval in which MGF is the only conventional gene, and (c) several single modifiers interact to modulate TGCT susceptibility, including dramatically reduced susceptibility in p53/+ SIJ/+ double mutant mice.
We propose four Specific Aims:
Specific Aim 1. What is the identity of the TGCT suppressor in Ay mutants and the enhancer in Kitl*SI mice?
Specific Aim 2. What is the nature of the interactions between TGCT susceptibility modifier genes?
Specific Aim 3. Does the Y chromosome affect TGCT susceptibility?
Specific Aim 4. Do mutations in RNA editing genes affect TGCT susceptibility?
Our discovery that the most potent TGCT modifier gene (Ter) probably involves anomalies in RNA editing raises exciting new opportunities to explore the role of this remarkable but poorly understood process in stem cell biology and TGCT susceptibility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Master regulators of unexplained variation in disease risk
-
批准号:10492766
-
项目类别:
-
资助金额:$191.92万
-
财政年份:2021
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Master regulators of unexplained variation in disease risk
-
批准号:10670982
-
项目类别:
-
资助金额:$192.26万
-
财政年份:2021
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Master regulators of unexplained variation in disease risk
-
批准号:10273583
-
项目类别:
-
资助金额:$191.32万
-
财政年份:2021
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Pilot Project Program
-
批准号:10675601
-
项目类别:
-
资助金额:$53.98万
-
财政年份:2017
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Pilot Project Program
-
批准号:10505156
-
项目类别:
-
资助金额:$53.12万
-
财政年份:2017
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
-
批准号:8722583
-
项目类别:
-
资助金额:$87.23万
-
财政年份:2010
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
-
批准号:8645834
-
项目类别:
-
资助金额:$69.87万
-
财政年份:2010
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
-
批准号:8517171
-
项目类别:
-
资助金额:$86.43万
-
财政年份:2010
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
-
批准号:8316233
-
项目类别:
-
资助金额:$19.23万
-
财政年份:2010
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
-
批准号:8152152
-
项目类别:
-
资助金额:$83.95万
-
财政年份:2010
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
-
批准号:7979938
-
项目类别:
-
资助金额:$84.8万
-
财政年份:2010
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Genetic Predisposition & Prevention of Neural Tube Defects (NTDs)
-
批准号:7906757
-
项目类别:
-
资助金额:$118.1万
-
财政年份:2009
-
负责人:JOSEPH H. NADEAU
-
依托单位:
7th Pathways, networks and Systems Medicine Conference
-
批准号:7750257
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2009
-
负责人:JOSEPH H. NADEAU
-
依托单位:
Genetic Predisposition & Prevention of Neural Tube Defects (NTDs)
-
批准号:7524590
-
项目类别:
-
资助金额:$118.53万
-
财政年份:2009
-
负责人:JOSEPH H. NADEAU
-
依托单位:
MOUSE GENETIC RESOURCES FOR MULTIGENIC DISEASE ANALYSIS: AIDS
-
批准号:7392005
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2006
-
负责人:JOSEPH H. NADEAU
-
依托单位:
MOUSE GENETIC RESOURCES FOR MULTIGENIC DISEASE ANALYSIS
-
批准号:7392006
-
项目类别:
-
资助金额:$69.81万
-
财政年份:2006
-
负责人:JOSEPH H. NADEAU
-
依托单位:
MOUSE GENETIC RESOURCES FOR MULTIGENIC DISEASE ANALYSIS: AIDS
-
批准号:7153951
-
项目类别:
-
资助金额:$6.59万
-
财政年份:2005
-
负责人:JOSEPH H. NADEAU
-
依托单位:
MOUSE GENETIC RESOURCES FOR MULTIGENIC DISEASE ANALYSIS
-
批准号:7153952
-
项目类别:
-
资助金额:$59.32万
-
财政年份:2005
-
负责人:JOSEPH H. NADEAU
-
依托单位:
MOUSE GENETIC RESOURCES FOR MULTIGENIC DISEASE ANALYSIS
-
批准号:6982655
-
项目类别:
-
资助金额:$63.32万
-
财政年份:2004
-
负责人:JOSEPH H. NADEAU
-
依托单位:
WORKSHOPS--MOUSE MUTAGENESIS
-
批准号:6670896
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2003
-
负责人:JOSEPH H. NADEAU
-
依托单位:
海外基金